5-Year Outcomes of Self-Expanding Transcatheter Versus Surgical Aortic Valve Replacement in High-Risk Patients

Mack, 2015, 5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial, Lancet, 385, 2477, 10.1016/S0140-6736(15)60308-7 Smith, 2011, Transcatheter versus surgical aortic-valve replacement in high-risk patients, N Engl J Med, 364, 2187, 10.1056/NEJMoa1103510 Adams, 2014, Transcatheter aortic-valve replacement with a self-expanding prosthesis, N Engl J Med, 370, 1790, 10.1056/NEJMoa1400590 Reardon, 2015, 2-Year outcomes in patients undergoing surgical or self-expanding transcatheter aortic valve replacement, J Am Coll Cardiol, 66, 113, 10.1016/j.jacc.2015.05.017 Deeb, 2016, 3-Year outcomes in high-risk patients who underwent surgical or transcatheter aortic valve replacement, J Am Coll Cardiol, 67, 2565, 10.1016/j.jacc.2016.03.506 Nishimura, 2017, 2017 AHA/ACC focused update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines, J Am Coll Cardiol, 70, 252, 10.1016/j.jacc.2017.03.011 Leon, 2011, Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium, J Am Coll Cardiol, 57, 253, 10.1016/j.jacc.2010.12.005 Capodanno, 2017, Eur Heart J, 38, 3382, 10.1093/eurheartj/ehx303 Popma, 2014, Transcatheter aortic valve replacement using a self-expanding bioprosthesis in patients with severe aortic stenosis at extreme risk for surgery, J Am Coll Cardiol, 63, 1972, 10.1016/j.jacc.2014.02.556 Johnston, 2015, Long-term durability of bioprosthetic aortic valves: implications from 12,569 implants, Ann Thorac Surg, 99, 1239, 10.1016/j.athoracsur.2014.10.070 Akins, 2008, Guidelines for reporting mortality and morbidity after cardiac valve interventions, J Thorac Cardiovasc Surg, 135, 732, 10.1016/j.jtcvs.2007.12.002 Riess, 2018, Long-term outcomes of the mosaic bioprosthesis, Ann Thorac Surg, 105, 763, 10.1016/j.athoracsur.2017.09.053 Schneider, 2018, Twenty-year experience with stentless biological aortic valve and root replacement: informing patients of risks and benefits, Eur J Cardiothorac Surg, 53, 1272, 10.1093/ejcts/ezx478 Wang, 2017, Bioprosthetic aortic valve durability: a meta-regression of published studies, Ann Thorac Surg, 104, 1080, 10.1016/j.athoracsur.2017.02.011 Forrest, 2018, Early outcomes with the Evolut PRO repositionable self-expanding transcatheter aortic valve with pericardial wrap, J Am Coll Cardiol Intv, 11, 160, 10.1016/j.jcin.2017.10.014 Grube, 2017, Clinical outcomes with a repositionable self-expanding transcatheter aortic valve prosthesis: the international FORWARD study, J Am Coll Cardiol, 70, 845, 10.1016/j.jacc.2017.06.045 Manoharan, 2015, Treatment of symptomatic severe aortic stenosis with a novel resheathable supra-annular self-expanding transcatheter aortic valve system, J Am Coll Cardiol Intv, 8, 1359, 10.1016/j.jcin.2015.05.015 Popma, 2017, Early clinical outcomes after transcatheter aortic valve replacement using a novel self-expanding bioprosthesis in patients with severe aortic stenosis who are suboptimal for surgery: results of the Evolut R U.S. study, J Am Coll Cardiol Intv, 10, 268, 10.1016/j.jcin.2016.08.050 Gaudiani, 2017, Causes of death from the randomized CoreValve US Pivotal High-Risk Trial, J Thorac Cardiovasc Surg, 153, 1293, 10.1016/j.jtcvs.2016.11.069 Messe, 2014, Stroke after aortic valve surgery: results from a prospective cohort, Circulation, 129, 2253, 10.1161/CIRCULATIONAHA.113.005084 Leon, 2016, Transcatheter or surgical aortic-valve replacement in intermediate-risk patients, N Engl J Med, 374, 1609, 10.1056/NEJMoa1514616 Reardon, 2017, Surgical or transcatheter aortic-valve replacement in intermediate-risk patients, N Engl J Med, 376, 1321, 10.1056/NEJMoa1700456